Overview
Biovia provides software solutions for scientific research and discovery. The company develops and maintains multiple specialized platforms: Discovery Studio for molecular modeling, Materials Studio for materials simulation, Pipeline Pilot for data integration and analysis, COSMOsuite for molecular property prediction, and TURBOMOLE for quantum chemistry calculations.
Key people
In the news
- A warm welcome to our new members: ◾ Bioventa helps life sciences companies turn promising science into commercial success through tailored commercial strategy and market access, from product launches to building commercial functions. ◾ CORTERIS helps life sciences and health organizations accelerate growth through hands-on expertise in business development, partnerships, funding and complex program execution. ◾ MainShift Innovation combines strategic advice, technology development and venture building to help organizations
- Last week we welcomed almost 100 participants (onsite and online) to our last MedTeG Medical Device Seminar of the year During two days Researchers, clinicians, entrepreneurs, industry professionals, and innovation experts explored one central question: how do we successfully translate promising medical technology research into solutions that reach patients and create healthcare impact? On day one, Prof Pascal Verdonck opened the seminar and positioned the impact of initiatives like these within the medtech valorisation
- Precision medicine promises therapies made for one patient. Each of them still has to be manufactured, from starting material that is different every time. Our CEO Jan Schrooten and Evan Claes will be at Science for health 2026 in Brussels on 10 November. This edition, Immunology reengineered, brings researchers, clinicians and industry together around the next generation of immune therapies, from CAR-T to engineered antibodies. Making sure a process is ready for manufacturing, that is where Antleron steps in. With scaled-down
- Policymakers are asking. Now SMEs will respond. The cabinets of Flemish innovation minister Matthias Diependaele and federal health minister Frank Vandenbroucke have asked for actionable recommendations directly from innovative #SMEs: ➡️ What pressures are you experiencing in Belgium’s health #innovation ecosystem, and which measures would make a real difference? At Science for Health 2026, the interactive closing panel brings this request directly to the ecosystem. 🔷 What should the government do in practical terms, both at
- There are still three upcoming practical sessions in our Ready to Scale, Ready to Fund program to strengthen your strategy. Don't miss out! ⬇️ Missed Session 1? No problem! Biovia members and HealthTech Investor Summit pitchers can also request access to the recording and catch up before joining the next sessions. 📈 05 November | #2: Master your go-to-market and IP strategy Turn your innovation into a credible market strategy and understand how IP can support your path to growth. 🔗 https://lnkd.in/eSWGX5rr 💡 17 November | #3:
- 240 million in fresh capital between this panel’s speakers. One question every healthtech founder wants answered: what will it take to get them to invest in you? In a cautious capital market, raising a new fund is an achievement in itself. But once the commitments are secured, the pressure shifts. Which innovations justify the risk? 📸 These 5 funds are part of a much bigger investment picture. Across the HealthTech Investor Summit pan-European community, investors have collectively raised €1.4 billion in 2025 and 2026 alone (and
- Bringing both Biotech and the Tech industry together at the Tech x Bio night in Ghent was a smart move. It was interesting to see talks from argenx and Orionis Biosciences outside the "normal scientific conference" setting that I am used to. Vice-versa it was also inspiring to see the tech-talks from Aikido Security and TechWolf in their kind of "natural Wintercircus" habitat. It's now the second time that I see Jeroen Van Hautte 🐺 showing live Claude Code sessions and I love the style 😁 The ambition to scale globally from day
- Explore how to move ATMP and RNA medicine from lab to patient. Registerations are now open! Biovia is proud partner in PRECISEU, giving its members and the Flemish ecosystem the opportunity to join this European training initiative and strengthen skills and collaborations. VLAIO - Flanders Innovation & Entrepreneurship | #stronggrowth
Alumni 2 went on to found or lead
Bernard SagaertBoard Member→Chief Executive Officer at etherna- PWard ServaesMember Board Of Directors→Co-Founder & Director at moveUP - digital therapies
Something wrong or missing? Send an update. Fixed within 24 hours.